José A Barrabés1, Alfredo Bardají2, Javier Jiménez-Candil3, Frutos del Nogal Sáez4, Vicente Bodí5, Nuria Basterra6, Elvira Marco7, Rafael Melgares8, José Cuñat de la Hoz9, Antonio Fernández-Ortiz10. 1. Servicio de Cardiología, Hospital Universitario Vall d'Hebron, VHIR, Universidad Autónoma de Barcelona, Barcelona, Spain. Electronic address: jabarrabes@vhebron.net. 2. Servicio de Cardiología, Hospital Universitario de Tarragona Joan XXIII, IIISPV, Universidad Rovira Virgili, Tarragona, Spain. 3. IBSAL-Servicio de Cardiología, Hospital Universitario de Salamanca, Salamanca, Spain. 4. Servicio de Medicina Intensiva, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain. 5. Servicio de Cardiología, Hospital Clínico Universitario, Universidad de Valencia, Incliva, Valencia, Spain. 6. Servicio de Cardiología, Hospital de Navarra, Pamplona, Navarra, Spain. 7. Sección de Cardiología, Hospital Virgen de los Lirios, Alcoy, Alicante, Spain. 8. Servicio de Cardiología, Hospital Universitario Virgen de las Nieves, Granada, Spain. 9. Servicio de Medicina Intensiva, Hospital Universitario La Fe, Valencia, Spain. 10. Servicio de Cardiología, Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain.
Abstract
INTRODUCTION AND OBJECTIVES: To identify the current mortality and management of patients admitted for suspected acute coronary syndrome in Spain. The last available registry (2004-2005) reported an in-hospital mortality of 5.7%. METHODS: The study included patients consecutively admitted between January and June 2012 at 44 hospitals selected at random. Information was collected on clinical course at admission and on events at 6 months. RESULTS: A total of 2557 patients admitted with suspected acute coronary syndrome were included: 788 (30.8%) with ST-segment elevation, 1602 (62.7%) without ST-segment elevation, and 167 (6.5%) with unclassified acute coronary syndrome. In-hospital mortality was 4.1% (6.6%, 2.4%, and 7.8% respectively), significantly lower than that observed for 2004-2005. Reperfusion treatment (most commonly, primary percutaneous coronary intervention) was administered to 85.7% of patients with ST-segment elevation attended within 12h. The median time from first medical contact to thrombolysis was 40 min and to balloon inflation, 120 min. Among patients without ST-segment elevation, coronary angiography was performed in 80.6%, percutaneous intervention in 52.0%, and surgery was indicated in 6.4%. Secondary prevention treatments at discharge was prescribed more often than in earlier registries. In patients alive at discharge (follow-up available for 97.1%), 6-month mortality was 3.8%. CONCLUSIONS: Mortality among patients with acute coronary syndrome in Spain was lower than that reported in the most recent published studies, in parallel with a more frequent use of the main treatments recommended.
INTRODUCTION AND OBJECTIVES: To identify the current mortality and management of patients admitted for suspected acute coronary syndrome in Spain. The last available registry (2004-2005) reported an in-hospital mortality of 5.7%. METHODS: The study included patients consecutively admitted between January and June 2012 at 44 hospitals selected at random. Information was collected on clinical course at admission and on events at 6 months. RESULTS: A total of 2557 patients admitted with suspected acute coronary syndrome were included: 788 (30.8%) with ST-segment elevation, 1602 (62.7%) without ST-segment elevation, and 167 (6.5%) with unclassified acute coronary syndrome. In-hospital mortality was 4.1% (6.6%, 2.4%, and 7.8% respectively), significantly lower than that observed for 2004-2005. Reperfusion treatment (most commonly, primary percutaneous coronary intervention) was administered to 85.7% of patients with ST-segment elevation attended within 12h. The median time from first medical contact to thrombolysis was 40 min and to balloon inflation, 120 min. Among patients without ST-segment elevation, coronary angiography was performed in 80.6%, percutaneous intervention in 52.0%, and surgery was indicated in 6.4%. Secondary prevention treatments at discharge was prescribed more often than in earlier registries. In patients alive at discharge (follow-up available for 97.1%), 6-month mortality was 3.8%. CONCLUSIONS: Mortality among patients with acute coronary syndrome in Spain was lower than that reported in the most recent published studies, in parallel with a more frequent use of the main treatments recommended.
Authors: C García-García; N Ribas; L L Recasens; O Meroño; I Subirana; A Fernández; A Pérez; F Miranda; H Tizón-Marcos; J Martí-Almor; J Bruguera; R Elosua Journal: BMC Cardiovasc Disord Date: 2017-05-26 Impact factor: 2.298
Authors: Ingo Ahrens; Oleg Averkov; Eduardo C Zúñiga; Alan Y Y Fong; Khalid F Alhabib; Sigrun Halvorsen; Muhamad A B S K Abdul Kader; Ricardo Sanz-Ruiz; Robert Welsh; Hongbin Yan; Philip Aylward Journal: Clin Cardiol Date: 2019-07-17 Impact factor: 2.882
Authors: Francisco Javier Félix-Redondo; Luis Lozano Mera; Luciano Consuegra-Sánchez; Fernando Giménez Sáez; Francisco Javier Garcipérez de Vargas; José María Castellano Vázquez; Daniel Fernández-Bergés Journal: Open Heart Date: 2016-02-26
Authors: Franz Goss; Johannes Brachmann; Christian W Hamm; Winfried Haerer; Nicolaus Reifart; Benny Levenson Journal: Vasc Health Risk Manag Date: 2017-04-06